How do preeclampsia and eclampsia differ?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Difference Between Eclampsia and Preeclampsia

Eclampsia is preeclampsia plus seizures—it represents the progression of preeclampsia to include convulsions that cannot be attributed to other causes. 1

Core Distinction

Preeclampsia is a multisystem syndrome of pregnancy characterized by:

  • New-onset hypertension (≥140/90 mmHg) after 20 weeks of gestation 1
  • Plus proteinuria (≥300 mg/24 hours) or evidence of maternal organ dysfunction (renal insufficiency, liver involvement, thrombocytopenia, pulmonary edema, or cerebral/visual disturbances) 1
  • The underlying pathophysiology involves placental dysfunction leading to widespread maternal endothelial dysfunction 1

Eclampsia is defined as:

  • The occurrence of seizures in a woman with preeclampsia that cannot be attributed to other causes 1, 2
  • Historically described since 100 AD as "seizures during pregnancy that abated with delivery" 1
  • Occurs in approximately 0.2% of preeclamptic patients 2
  • Can develop antepartum, intrapartum, or postpartum (even after delivery) 3, 4

Clinical Implications for Morbidity and Mortality

The progression from preeclampsia to eclampsia dramatically escalates maternal and fetal risk:

  • Preeclampsia alone presents acute risks to mother and baby, including growth restriction, preterm delivery, placental abruption, and maternal organ damage 1
  • Eclampsia adds the life-threatening complication of seizures with associated risks of maternal cerebral hemorrhage, aspiration, hypoxia, and fetal compromise 1
  • Both conditions resolve after delivery of the placenta, confirming the placenta as the essential driver of disease 1, 3

Warning Signs of Progression to Eclampsia

Symptoms indicating severe preeclampsia at risk of progressing to eclampsia include:

  • Persistent severe headache unresponsive to treatment 1, 5
  • Visual disturbances (scotomata, blurred vision, photophobia) 1, 5
  • Right upper quadrant or epigastric pain (from hepatic edema/hemorrhage) 5, 3
  • Hyperreflexia and clonus (though nonspecific) 5, 3

Management Differences

For preeclampsia:

  • Magnesium sulfate is used for seizure prophylaxis in women with severe features or neurological symptoms 4, 2
  • Antihypertensive therapy targets severe hypertension (≥160/110 mmHg) 4
  • Delivery timing depends on gestational age, maternal condition, and fetal status 4

For eclampsia:

  • Magnesium sulfate becomes therapeutic (not just prophylactic) to control active seizures 2
  • Loading dose of 4 g IV or 10 g IM, followed by maintenance infusion 4
  • Immediate delivery is typically indicated once maternal condition is stabilized 4
  • Diazepam may supplement magnesium sulfate if seizures persist 2

Common Pitfalls to Avoid

  • Do not assume preeclampsia is "mild" based on blood pressure alone—all preeclampsia can progress unpredictably to eclampsia or other life-threatening complications 4, 6
  • Do not delay magnesium sulfate prophylaxis in women with severe features or neurological symptoms, as eclampsia can develop rapidly 4, 2
  • Do not discontinue monitoring immediately after delivery—eclampsia can occur postpartum, requiring continued vigilance for at least 72 hours 3, 4
  • Do not use serum uric acid or degree of proteinuria to predict eclampsia risk; clinical features (headache, visual changes) are more relevant 4

Long-term Cardiovascular Implications

Both conditions increase lifetime cardiovascular risk, though the data primarily address preeclampsia history:

  • Women with preeclampsia history have 75% increased cardiovascular mortality risk (OR 1.75) 5
  • The risk is amplified with severe preeclampsia (OR 2.74 vs. 2.24 for moderate disease) 5
  • Mandatory 3-month postpartum follow-up is required to confirm resolution and initiate cardiovascular screening 5, 3
  • Annual lifelong follow-up is recommended for all women with preeclampsia or eclampsia history 5, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of preeclampsia and eclampsia.

Clinical pharmacy, 1992

Guideline

Preeclampsia Resolution and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management and Treatment of Preeclampsia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Preeclampsia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Preeclampsia and hypertensive disorders of pregnancy.

American family physician, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.